Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Chinese Hamster Ovary (CHO) Cell Line 1.4.3 Baby Hamster Kidney (BHK) Cell Line 1.4.4 Human Embryonic Kidney (HEK) Cell Line 1.4.5 Others 1.5 Market by Application 1.5.1 Global Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2025) 1.5.2 Hemophilia A 1.5.3 Hemophilia B 1.5.4 Von Willebrand Disease 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Recombinant Plasma Protein Therapeutics Market Size 2.2 Recombinant Plasma Protein Therapeutics Growth Trends by Regions 2.2.1 Recombinant Plasma Protein Therapeutics Market Size by Regions (2014-2025) 2.2.2 Recombinant Plasma Protein Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Recombinant Plasma Protein Therapeutics Market Size by Manufacturers 3.1.1 Global Recombinant Plasma Protein Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Recombinant Plasma Protein Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Recombinant Plasma Protein Therapeutics Key Players Head office and Area Served 3.3 Key Players Recombinant Plasma Protein Therapeutics Product/Solution/Service 3.4 Date of Enter into Recombinant Plasma Protein Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) 4.2 Global Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 5.2 Recombinant Plasma Protein Therapeutics Key Players in United States 5.3 United States Recombinant Plasma Protein Therapeutics Market Size by Type 5.4 United States Recombinant Plasma Protein Therapeutics Market Size by Application 6 Europe 6.1 Europe Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 6.2 Recombinant Plasma Protein Therapeutics Key Players in Europe 6.3 Europe Recombinant Plasma Protein Therapeutics Market Size by Type 6.4 Europe Recombinant Plasma Protein Therapeutics Market Size by Application 7 China 7.1 China Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 7.2 Recombinant Plasma Protein Therapeutics Key Players in China 7.3 China Recombinant Plasma Protein Therapeutics Market Size by Type 7.4 China Recombinant Plasma Protein Therapeutics Market Size by Application 8 Japan 8.1 Japan Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 8.2 Recombinant Plasma Protein Therapeutics Key Players in Japan 8.3 Japan Recombinant Plasma Protein Therapeutics Market Size by Type 8.4 Japan Recombinant Plasma Protein Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 9.2 Recombinant Plasma Protein Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Type 9.4 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Application 10 India 10.1 India Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 10.2 Recombinant Plasma Protein Therapeutics Key Players in India 10.3 India Recombinant Plasma Protein Therapeutics Market Size by Type 10.4 India Recombinant Plasma Protein Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Recombinant Plasma Protein Therapeutics Market Size (2014-2019) 11.2 Recombinant Plasma Protein Therapeutics Key Players in Central & South America 11.3 Central & South America Recombinant Plasma Protein Therapeutics Market Size by Type 11.4 Central & South America Recombinant Plasma Protein Therapeutics Market Size by Application 12 International Players Profiles 12.1 CSL Limited 12.1.1 CSL Limited Company Details 12.1.2 Company Description and Business Overview 12.1.3 Recombinant Plasma Protein Therapeutics Introduction 12.1.4 CSL Limited Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.1.5 CSL Limited Recent Development 12.2 Shire (Takeda Pharmaceutical Company Limited) 12.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Details 12.2.2 Company Description and Business Overview 12.2.3 Recombinant Plasma Protein Therapeutics Introduction 12.2.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.2.5 Shire (Takeda Pharmaceutical Company Limited) Recent Development 12.3 Octapharma 12.3.1 Octapharma Company Details 12.3.2 Company Description and Business Overview 12.3.3 Recombinant Plasma Protein Therapeutics Introduction 12.3.4 Octapharma Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.3.5 Octapharma Recent Development 12.4 Novo Nordisk 12.4.1 Novo Nordisk Company Details 12.4.2 Company Description and Business Overview 12.4.3 Recombinant Plasma Protein Therapeutics Introduction 12.4.4 Novo Nordisk Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.4.5 Novo Nordisk Recent Development 12.5 Bayer 12.5.1 Bayer Company Details 12.5.2 Company Description and Business Overview 12.5.3 Recombinant Plasma Protein Therapeutics Introduction 12.5.4 Bayer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.5.5 Bayer Recent Development 12.6 Bioverativ Therapeutics, Inc. (Sanofi) 12.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Details 12.6.2 Company Description and Business Overview 12.6.3 Recombinant Plasma Protein Therapeutics Introduction 12.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Recent Development 12.7 Aptevo Therapeutics 12.7.1 Aptevo Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 Recombinant Plasma Protein Therapeutics Introduction 12.7.4 Aptevo Therapeutics Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.7.5 Aptevo Therapeutics Recent Development 12.8 Pharming Group 12.8.1 Pharming Group Company Details 12.8.2 Company Description and Business Overview 12.8.3 Recombinant Plasma Protein Therapeutics Introduction 12.8.4 Pharming Group Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.8.5 Pharming Group Recent Development 12.9 Pfizer 12.9.1 Pfizer Company Details 12.9.2 Company Description and Business Overview 12.9.3 Recombinant Plasma Protein Therapeutics Introduction 12.9.4 Pfizer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) 12.9.5 Pfizer Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Recombinant Plasma Protein Therapeutics Key Market Segments Table Key Players Recombinant Plasma Protein Therapeutics Covered Table Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type 2014-2025 Figure Chinese Hamster Ovary (CHO) Cell Line Figures Table Key Players of Chinese Hamster Ovary (CHO) Cell Line Figure Baby Hamster Kidney (BHK) Cell Line Figures Table Key Players of Baby Hamster Kidney (BHK) Cell Line Figure Human Embryonic Kidney (HEK) Cell Line Figures Table Key Players of Human Embryonic Kidney (HEK) Cell Line Figure Others Figures Table Key Players of Others Table Global Recombinant Plasma Protein Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Hemophilia A Case Studies Figure Hemophilia B Case Studies Figure Von Willebrand Disease Case Studies Figure Others Case Studies Figure Recombinant Plasma Protein Therapeutics Report Years Considered Table Global Recombinant Plasma Protein Therapeutics Market Size 2014-2025 (Million US$) Figure Global Recombinant Plasma Protein Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2014-2019 Figure Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2014-2019 Figure Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Recombinant Plasma Protein Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Recombinant Plasma Protein Therapeutics Market Share by Manufacturers in 2018 Table Global Recombinant Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Recombinant Plasma Protein Therapeutics Product/Solution/Service Table Date of Enter into Recombinant Plasma Protein Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Size Share by Type (2014-2019) Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019) Table Global Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Recombinant Plasma Protein Therapeutics Market Size Share by Application (2014-2019) Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application in 2018 Figure United States Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table United States Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table United States Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure Europe Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table Europe Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table Europe Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure China Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table China Recombinant Plasma Protein Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table China Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure Japan Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table Japan Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table Japan Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure India Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table India Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table India Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Figure Central & South America Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019) Table Central & South America Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019) Table Central & South America Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019) Table CSL Limited Company Details Table CSL Limited Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) (Million US$) Figure CSL Limited Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table CSL Limited Recent Development Table Shire (Takeda Pharmaceutical Company Limited) Company Details Table Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Shire (Takeda Pharmaceutical Company Limited) Recent Development Table Octapharma Company Details Table Octapharma Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Octapharma Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Octapharma Recent Development Table Novo Nordisk Company Details Table Novo Nordisk Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Novo Nordisk Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Novo Nordisk Recent Development Table Bayer Company Details Table Bayer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Bayer Recent Development Table Bioverativ Therapeutics, Inc. (Sanofi) Company Details Table Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Bioverativ Therapeutics, Inc. (Sanofi) Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Bioverativ Therapeutics, Inc. (Sanofi) Recent Development Table Aptevo Therapeutics Company Details Table Aptevo Therapeutics Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Aptevo Therapeutics Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Aptevo Therapeutics Recent Development Table Pharming Group Company Details Table Pharming Group Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Pharming Group Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Pharming Group Recent Development Table Pfizer Company Details Table Pfizer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019) Table Pfizer Recent Development Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Recombinant Plasma Protein Therapeutics Market Size Share by Regions (2019-2025) Figure Global Recombinant Plasma Protein Therapeutics Market Size Share by Regions in 2025 Figure United States Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Recombinant Plasma Protein Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Recombinant Plasma Protein Therapeutics Market Size by Product (2019-2025) Figure Global Recombinant Plasma Protein Therapeutics Market Size by Product in 2025 Table Global Recombinant Plasma Protein Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Recombinant Plasma Protein Therapeutics Market Size by Application (2019-2025) Figure Global Recombinant Plasma Protein Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

CSL Limited Shire (Takeda Pharmaceutical Company Limited) Octapharma Novo Nordisk Bayer Bioverativ Therapeutics, Inc. (Sanofi) Aptevo Therapeutics Pharming Group Pfizer